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Cyclic Vomiting Syndrome and Migraine in Children
Yi-Pei Lin, Yen-Hsuan Ni, Wen-Chin Weng,* Wang-Tso Lee
Background: Cyclic vomiting syndrome (CVS) is an episodic nausea and non-bilious vomiting disorder
characterized by recurrent stereotypic symptoms with disease-free intervals. CVS in children is associated
with a high prevalence of migraine, and is commonly considered a precursor to migraine. This study
aimed to investigate the clinical manifestations of pediatric CVS and its prognosis, and to clarify its rela-
tionship with the risk of migraine development in children.
Methods: The clinical features of children diagnosed with CVS before the age of 18 years at the designated
hospital were retrospectively studied over the past 30 years (1976 − 2006) based on the Rome III or ICHD
II criteria. Clinical evaluations, including age of onset, sex, family history, symptoms and duration during
attacks, frequency, trigger events, electroencephalogram, treatment and subsequent development of 
migraine were assessed from chart records and telephone interviews.
Results: Thirty-five children (17 males and 18 females) were enrolled. Their age of onset ranged from 2 to
17 years (mean, 6.8 ± 3.1 years) and frequency of attacks ranged from once to 36 times per year (mean,
8.2 ± 7.6 times). Duration of symptoms during each attack ranged from 1 to 45 days (mean, 5.9 ± 7.3
days). Of 20 children assessed for migraine development, seven subsequently developed typical migraine
symptoms. There was younger onset age in the migraine-positive subgroup (5 ± 1.7 years) than in the mi-
graine-negative subgroup (8.9 ± 3 years; p = 0.001). Co-morbid headache during CVS attack was also more
evident in the migraine-positive subgroup (28.6% vs. 0%).
Conclusion: Results of the study show that younger onset age and headache during CVS attacks may have
increased risk of migraine development. Large-scale prospective studies are warranted to further clarify the
relationship between CVS and migraine.
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Cyclic vomiting syndrome (CVS) is an episodic
nausea and non-bilious vomiting disorder char-
acterized by recurrent stereotypic symptoms 
with disease-free intervals in otherwise healthy
children.1−4 Patients usually have rapid onset re-
lentless vomiting, abdominal pain, and fatigue
lasting for hours to days. Factors that trigger at-
tacks are commonly identified, and symptoms are
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self-limited and resolve spontaneously without
special treatment.5,6 Diagnosis is based on his-
tory, clinical presentation, and exclusion of any
metabolic, gastro-intestinal, or central nervous
system structural or biochemical disorders.7−9
The International Classification of Headache
Disorder 2004 (ICHD-II) or Rome III diagnostic
criteria are mostly used for CVS diagnosis 
(Table 1).
CVS often begins in childhood and is a com-
mon cause of recurrent vomiting in children.10,11
Although its etiology is still undefined, it is com-
monly considered a precursor of migraine or mi-
graine equivalent. Migraine, abdominal migraine,
and CVS have similar clinical courses, with episodic
attacks separated by symptom-free intervals.12
There are also some similarities in their sympto-
matology, such that CVS patients may have head-
ache or abdominal pain during vomiting attacks.7
Patients with CVS have higher prevalence of
migraine than the general population (22% and
5%, respectively).13,14 Despite the lack of specific
laboratory tests for diagnosing CVS and migraine,
there are some links between CVS and subsequent
migraine. The present study retrospectively inves-
tigated the correlation between clinical manifesta-
tions of CVS and risks of migraine development
in children to determine some clinical patterns
indicative of a stronger relationship.
Patients and Methods
Children aged < 18 years diagnosed to have CVS
at the designated hospital in the past 30 years
(1976 − 2006) were all reviewed retrospectively
and evaluated by pediatric neurologists and 
pediatric gastroenterologists. The diagnosis of
CVS was based on clinical presentations, physi-
cal examination, and exclusion of any metabolic,
gastro-intestinal, or central nervous system struc-
tural or biochemical disorders by serial work-up
on admission. Thirty-five patients were enrolled
in the present study based on the Rome III or
ICHD II criteria.
Clinical evaluations, including age of onset,
sex, family history, symptoms and duration dur-
ing attacks, frequency of attacks, trigger events,
electroencephalogram, and treatment during at-
tacks, were performed by chart review. Clinical
follow-up information, including subsequent
development of migraine, was obtained from the
outpatient clinics and by telephone interviews.
The diagnosis of migraine was made using the
Table 1. Diagnostic criteria of cyclic vomiting syndrome
ICHD II Criteria for CVS
1. At least 5 attacks fulfilling criteria 2 and 3
2. Episodic attacks, stereotypical in the individual patient, of intense nausea and vomiting lasting from 1 hr to 5 d
3. Vomiting during attacks occurs at least 4 times hr for at least 1 hr
4. Symptom-free between attacks
5. Not attributed to another disorder
Rome III Criteria for CVS
At least 3 mo, with onset at least 6 mo previously of
1. Stereotypical episodes of vomiting regarding onset (acute) and duration (< 1 wk)
2. Three or more discrete episodes in the prior year
3. Absence of nausea and vomiting in between the episodes
4. There are no metabolic, gastrointestinal, or central nervous system structural or biochemical disorders
5. Supportive criteria: personal or family history of migraine headaches
CVS = cyclic vomiting syndrome. hr = hour(s); mo = month(s); yr = year(s).
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ICHD-II criteria (international classification of
headache disorder, 2nd).15
Statistical analysis
Statistical analysis was performed with STATA
Version 10.0. Gender, symptoms during attacks,
electroencephalography, and family history of
migraine were compared between the migraine-
positive and migraine-negative groups using
Fisher’s exact test. Mann-Whitney test was used
for continuous variables, including age, frequency,
and duration. A p < 0.05 was considered statisti-
cally significant.
Results
Of the 35 children (17 males and 18 females)
enrolled, the age of onset ranged from 2 to 17
years (mean, 6.8 ± 3.1 years). The frequency of at-
tacks ranged from 1 to 36 times per year (mean,
8.2 ± 7.6 times) while the duration of CVS symp-
toms during each attack ranged from 1 to 45 days
(mean, 5.9 ± 7.3 days).
During vomiting episodes, 71% and 11% of
patients had abdominal pain and headache, respec-
tively. Triggering events, including stress, fever, and
upper respiratory tract infection, occurred in 11
cases (31%). No cases had a family history of CVS,
although seven cases (20%) had migraine his-
tory on their maternal side and one (3%) on the
paternal side.
Electroencephalography was performed in 33
patients, and 16 (46%) showed slow background
activity, while four (11%) showed focal epilepti-
form discharges (Table 2). All 35 received sup-
portive treatment of parenteral fluid, electrolyte
replacement, and anti-emetic agents. Six received
prophylactic therapy of flunarizine upon discharge,
but were lost to follow-up.
Twenty patients were followed up in the hos-
pital or by telephone interviews. Their average
follow-up period was 7.5 years (range, 2–12
years). They were classified into two groups.
Seven patients subsequently developed typical
migraine symptoms that met the ICHD-II for 
Table 2. Clinical manifestations of patientsa
CVS patients 
(n = 35)
Gender
Male 17 (48)
Female 18 (52)
Onset age (yr)
Mean ± SD 6.8 ± 3.1
Range 2 – 17
Family history of migraine
Maternal 7 (20)
Paternal 1 (3)
No family history 28 (77)
Symptoms during attack
Vomiting 35 (100)
Abdominal pain 25 (71)
Headache 4 (11)
Others (dizziness, lethargy, 
diarrhea) 2 (5)
Frequency (times/yr)
Mean ± SD 8.2 ± 7.6
Range 1–36
Duration of CVS attack (d)
Mean ± SD 5.9 ± 7.3
Range 1–45
Trigger events
Yes 11 (31)
No 24 (69)
EEG pattern
Slow wave 16 (46)
Focal/Diffuse 8(23)/8(23)
Focal epileptiform discharges 4 (11)
14 and 6 positive spikes 6 (17)
Negative finding 11 (31)
Not done 2 (6)
Migraine development
Yes 7 (20)
No 13 (37)
Lost to follow-up 15 (43)
aData are presented as n (%), mean±SD or range. EEG= electro-
encephalography; CVS= cyclic vomiting syndrome; SD= standard
deviation.
migraine in an average follow-up period of 
6.7 years (range: 2–12 years) and were defined as
the migraine-positive group. The other 13 patients
did not develop migraine in an average follow-
up period of 7.8 years (range: 2–12 years) and
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were defined as the migraine-negative group
(Table 3).
Through follow-up (average, 7.5 years; range,
2–12 years) by telephone or outpatient clinics
interviews conducted by pediatric neurologists,
there was note of younger onset age of CVS in the
migraine-positive group (5 ± 1.7 years) than in the
migraine-negative group (8.9 ± 3 years; p= 0.001).
The incidence of headache during CVS attack
was not significantly different between the two
groups (2/7 vs. 0/13, p = 0.111), which may be
due to a small number of patients. Patients with
subsequent migraine tended to have higher inci-
dence of headache during CVS attack compared
with the migraine-negative group (28.6% vs. 0%).
Gender, duration and frequency of attacks, elec-
troencephalogram, and family history of migraine
did not differ between the two groups.
Discussion
Although the direct correlation between CVS and
migraine has not been confirmed, their relation-
ship has been investigated in previous studies.13,14
Li et al in 1999 found some differences in the
clinical parameters between migraine-associated
and non-migraine-associated CVS patients. Milder
vomiting episodes, more typical migraine symp-
toms (i.e. abdominal pain, headache during 
attacks, social withdrawal, photophobia, and
more triggering events) are more common in mi-
graine-associated patients. They also had higher
response rates to anti-migraine therapy.14
In the present study, there is a higher inci-
dence (35%) of subsequent migraine compared
with previous studies, which may be related to a
longer follow-up period in this study. The average
Table 3. Development of migraine and clinical characteristics (n = 20)
Migraine (+) Migraine (–)
p
(n = 7) (n = 13)
Gender (n) 0.356
Male 3 9
Female 4 4
Mean onset age (yr) 5 ± 1.7 8.9 ± 3.3 0.001
Frequency (Mean, times/yr) 4.5 9.4 0.498
Duration (Mean, d) 5.9 7.6 0.523
Symptoms during attack (n)
Abdominal pain 0.613
Yes 3 3
No 4 10
Headache during CVS attack 0.111
Yes 2 0
No 5 13
EEG pattern (n) 0.876
Slow wave 5 6
Focal spikes 1 1
14 and 6 positive spikes 0 2
Negative finding 1 2
Family history of migraine (n) 1.000
Maternal 2 3
Paternal 0 0
No family history 5 10
EEG = electroencephalography; CVS = cyclic vomiting syndrome.
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follow-up period was 7.5 years (range, 2–12
years). As such, the incidence of subsequent mi-
graine development may be more accurate. The
age of the study patients is also relatively young,
and some may not have reached adolescence 
at the time of enrollment. It may thus underesti-
mate the incidence of subsequent migraine 
development.
The results here show younger onset age of
CVS in the migraine-positive group, which is dif-
ferent from previous studies. Li et al showed that
there is no significant difference in the age of
onset between the two study groups used in their
investigation. They defined patients without mi-
graine symptoms but with family history of mi-
graine as the migraine-associated group. By
contrast, the criteria for patients enrolled in the
current study are more exact than Li’s in searching
for risk factors of migraine development in CVS
patients.14 This study indicates that younger age of
onset in CVS may have stronger correlation with
subsequent migraine development (p = 0.001).
The incidence of associated symptoms in the
study patients, including abdominal pain and
headache (71% and 11%), is remarkably lower
than in previous studies.1,14,16 Although the inci-
dence of headache during CVS episodes was low in
the present study, there is a higher incidence of co-
morbid headache in the migraine-positive group
(28.6%) than in the migraine-negative group (0%),
although not statistically significant. Patients with
headache during cyclic vomiting attack tend to
develop subsequent migraine more often than
patients without headache. Thus, headache dur-
ing attacks may indicate a migraine character of
CVS patients and disclose the relationship be-
tween migraine and CVS.
However, significant differences between 
migraine- and non-migraine-associated CVS in pre-
vious studies, including family history of migraine,
number of episodes, clinical manifestations with
abdominal pain, photophobia, withdrawal symp-
toms, and more triggering events, are not noted
in the current study. Triggering events, occurring
in 11 cases (31%), are slightly lower than a previ-
ous study.1,3 The majority have episodes triggered
by infection (mostly by upper airway infection)
and stress. According to previous literature, vari-
ous events like infection, psychologic stress, diet,
lack of sleep, physical exhaustion, atopic events,
motion sickness, and menses can trigger episodes.16
Such trigger events are difficult to determine in a
retrospective study.
Maternal inheritance of CVS has been de-
scribed in many reports, with mitochondrial in-
heritance as a sensible hypothesis because of a
higher degree of maternal inheritance in CVS
and migraine.13,14,16,17 Although only 20% of pa-
tients here have maternal family history of mi-
graine, maternal inheritance remains evident in
this study, as previously.
Although abnormal results of electroen-
cephalography have been emphasized in previous
literature, the role of EEG in diagnosing migraine
is controversial.18−20 Few studies mention the re-
lationship between electroencephalography results
and CVS. Several small quantitative EEG studies
of headache and cyclic vomiting reveal increased
delta activities during an episodic attack.18,21 In
the current study, 33 patients received an elec-
troencephalogram exam during the CVS attack.
Their results included focal or diffuse slow waves
in 16 patients (46%), focal spikes in four pa-
tients (11%), and 14 and six positive spikes in six
patients (17%; Table 2). These observations show
a high incidence of slow activities (46%) during
CVS attack in this study. There is difficulty com-
paring our findings with previous data due to
scarcity of literature. Focal or generalized slow
activities may be a particular pattern of CVS but
more cases are needed to confirm this. Wang et al
found that 14 and six positive spikes were more
common in patients with abdominal pain,
headache, and other autonomic symptoms.22
Only six patients (17%) have 14 and six positive
spikes in EEG during an acute episode of CVS.
The present study did not find 14 and six posi-
tive spikes as a significant risk factor in migraine
development.
A previous study mentions a higher response
rate to anti-migraine treatment in the migraine-
associated group.14 In the present study, 35 cases
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received supportive treatment during CVS attacks.
Six had prophylactic therapy with flunarizine as
a discharge medicine, but were lost to follow-up.
However, because of a limited case number and
the retrospective design in this study, it is diffi-
cult to establish a definitive relationship between
treatment response and migraine development.
In conclusion, there is a significant correla-
tion between clinical manifestations of CVS and
subsequent migraine development. Despite the
small case number and the retrospective design,
results here showed that younger onset age of
CVS and headache during attacks may indicate
increased risk of migraine. These results provide
a new insight regarding subsequent migraine de-
velopment in children with CVS, particularly if
there is an earlier onset age or headache during
CVS attack. Large-scale prospective studies are
warranted to further clarify the relationship be-
tween CVS and migraine.
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